Emcure Pharma Files For ?4,500 Crore IPO
[email protected]07 Oct, 2021News
Emcure Pharmaceuticals Limited, one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas, has filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) to raise funds via initial public offering (IPO).
Related Bookmarks
- Emcure Pharma Files Draft Paper For Rs 5,000 Cr IPO
- Bain Capital-Backed Emcure Pharmaceuticals Files DRHP For IPO With Sebi
- Wholesale DID
- Emcure Pharmaceuticals Files Draft Paper For Rs 4,500-Rs 5000 Crore IPO
- Cost-effective Abstract Writing outsourcing services
- Indian Air Force Day 2021: Know How IAF Is Celebrating Its 89th Anniversary
- The TEAM Companies Form Strategic Alliance with Peach
- DIDWW & Daktela team up for extended contact center reach
- Accenture Acquires Advoco for Intelligent Asset Management Sol.
- Mandiant Appoints Dee Dee Acquista as VP of Channel Sales
Recent Profiles
T91k Login
Figure Shipping
Deventer Dakdekker
Le-minh Chau
Thabet
Broden Millworks And Supply
Advocate Nitin Kumar Vashista
Ampelis
Swiftwave Digital
Sc88